Annual CFO
$27.00 M
-$226.52 M-89.35%
31 December 2023
Summary:
Fulgent Genetics annual cash flow from operations is currently $27.00 million, with the most recent change of -$226.52 million (-89.35%) on 31 December 2023. During the last 3 years, it has fallen by -$113.63 million (-80.80%). FLGT annual CFO is now -94.99% below its all-time high of $538.58 million, reached on 31 December 2021.FLGT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$15.51 M
-$19.79 M-461.94%
30 September 2024
Summary:
Fulgent Genetics quarterly cash flow from operations is currently -$15.51 million, with the most recent change of -$19.79 million (-461.94%) on 30 September 2024. Over the past year, it has dropped by -$25.75 million (-251.46%). FLGT quarterly CFO is now -106.65% below its all-time high of $233.18 million, reached on 31 March 2021.FLGT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$10.97 M
-$25.75 M-70.11%
30 September 2024
Summary:
Fulgent Genetics TTM cash flow from operations is currently $10.97 million, with the most recent change of -$25.75 million (-70.11%) on 30 September 2024. Over the past year, it has dropped by -$34.30 million (-75.76%). FLGT TTM CFO is now -98.16% below its all-time high of $595.75 million, reached on 30 September 2021.FLGT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
FLGT Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -89.3% | -251.5% | -75.8% |
| 3 y3 years | -80.8% | -110.2% | -98.2% |
| 5 y5 years | +4100.4% | -497.4% | +71.2% |
FLGT Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -95.0% | at low | -108.2% | at low | -98.2% | at low |
| 5 y | 5 years | -95.0% | +4100.4% | -106.7% | at low | -98.2% | +1375.1% |
| alltime | all time | -95.0% | +714.1% | -106.7% | at low | -98.2% | +507.4% |
Fulgent Genetics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$15.51 M(-461.9%) | $10.97 M(-70.1%) |
| June 2024 | - | $4.29 M(-41.0%) | $36.72 M(-12.9%) |
| Mar 2024 | - | $7.27 M(-51.3%) | $42.18 M(+56.2%) |
| Dec 2023 | $27.00 M(-89.3%) | $14.93 M(+45.8%) | $27.00 M(-40.4%) |
| Sept 2023 | - | $10.24 M(+5.2%) | $45.28 M(-18.9%) |
| June 2023 | - | $9.74 M(-223.1%) | $55.81 M(-2.4%) |
| Mar 2023 | - | -$7.91 M(-123.8%) | $57.20 M(-77.4%) |
| Dec 2022 | $253.52 M(-52.9%) | $33.21 M(+59.8%) | $253.52 M(-14.8%) |
| Sept 2022 | - | $20.78 M(+86.7%) | $297.40 M(-30.6%) |
| June 2022 | - | $11.13 M(-94.1%) | $428.82 M(-13.2%) |
| Mar 2022 | - | $188.41 M(+144.4%) | $493.81 M(-8.3%) |
| Dec 2021 | $538.58 M(+283.0%) | $77.09 M(-49.4%) | $538.58 M(-9.6%) |
| Sept 2021 | - | $152.20 M(+100.0%) | $595.75 M(+31.5%) |
| June 2021 | - | $76.11 M(-67.4%) | $452.96 M(+21.6%) |
| Mar 2021 | - | $233.18 M(+73.7%) | $372.44 M(+164.8%) |
| Dec 2020 | $140.63 M | $134.26 M(+1326.0%) | $140.63 M(+2147.9%) |
| Sept 2020 | - | $9.41 M(-313.5%) | $6.26 M(+740.9%) |
| June 2020 | - | -$4.41 M(-422.8%) | $744.00 K(-87.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $1.37 M(-1277.6%) | $5.83 M(+5.6%) |
| Dec 2019 | $5.52 M(-917.3%) | -$116.00 K(-103.0%) | $5.52 M(-13.9%) |
| Sept 2019 | - | $3.90 M(+478.2%) | $6.41 M(+166.8%) |
| June 2019 | - | $675.00 K(-36.0%) | $2.40 M(+43.8%) |
| Mar 2019 | - | $1.05 M(+35.6%) | $1.67 M(-347.6%) |
| Dec 2018 | -$675.00 K(-150.7%) | $778.00 K(-841.0%) | -$675.00 K(-74.9%) |
| Sept 2018 | - | -$105.00 K(+84.2%) | -$2.69 M(+29.0%) |
| June 2018 | - | -$57.00 K(-95.6%) | -$2.09 M(+42.3%) |
| Mar 2018 | - | -$1.29 M(+4.0%) | -$1.47 M(-210.3%) |
| Dec 2017 | $1.33 M(-69.8%) | -$1.24 M(-348.2%) | $1.33 M(-65.2%) |
| Sept 2017 | - | $500.00 K(-11.3%) | $3.83 M(-7.2%) |
| June 2017 | - | $564.00 K(-62.6%) | $4.12 M(-18.1%) |
| Mar 2017 | - | $1.51 M(+20.3%) | $5.04 M(+14.4%) |
| Dec 2016 | $4.41 M(-554.6%) | $1.25 M(+57.1%) | $4.41 M(+39.8%) |
| Sept 2016 | - | $798.00 K(-46.0%) | $3.15 M(+33.9%) |
| June 2016 | - | $1.48 M(+68.9%) | $2.35 M(+168.9%) |
| Mar 2016 | - | $875.00 K | $875.00 K |
| Dec 2015 | -$969.00 K(-78.0%) | - | - |
| Dec 2014 | -$4.40 M | - | - |
FAQ
- What is Fulgent Genetics annual cash flow from operations?
- What is the all time high annual CFO for Fulgent Genetics?
- What is Fulgent Genetics annual CFO year-on-year change?
- What is Fulgent Genetics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Fulgent Genetics?
- What is Fulgent Genetics quarterly CFO year-on-year change?
- What is Fulgent Genetics TTM cash flow from operations?
- What is the all time high TTM CFO for Fulgent Genetics?
- What is Fulgent Genetics TTM CFO year-on-year change?
What is Fulgent Genetics annual cash flow from operations?
The current annual CFO of FLGT is $27.00 M
What is the all time high annual CFO for Fulgent Genetics?
Fulgent Genetics all-time high annual cash flow from operations is $538.58 M
What is Fulgent Genetics annual CFO year-on-year change?
Over the past year, FLGT annual cash flow from operations has changed by -$226.52 M (-89.35%)
What is Fulgent Genetics quarterly cash flow from operations?
The current quarterly CFO of FLGT is -$15.51 M
What is the all time high quarterly CFO for Fulgent Genetics?
Fulgent Genetics all-time high quarterly cash flow from operations is $233.18 M
What is Fulgent Genetics quarterly CFO year-on-year change?
Over the past year, FLGT quarterly cash flow from operations has changed by -$25.75 M (-251.46%)
What is Fulgent Genetics TTM cash flow from operations?
The current TTM CFO of FLGT is $10.97 M
What is the all time high TTM CFO for Fulgent Genetics?
Fulgent Genetics all-time high TTM cash flow from operations is $595.75 M
What is Fulgent Genetics TTM CFO year-on-year change?
Over the past year, FLGT TTM cash flow from operations has changed by -$34.30 M (-75.76%)